Scholars call for Paris Accord-style global agreement to combat emergence of ‘superbugs’
25 March 2022
Public health experts have long been concerned by the emergence of so-called ‘superbugs’ — existing bacterial, viral, or fungal pathogens that have evolved to evade the antibiotics, antivirals and antifungals developed to kill them. The scope and severity of antimicrobial resistance (AMR) and the urgent need for a co-ordinated global response are the subjects of a new paper, co-authored by 25 scholars.
Further reading: Science Daily
Author(s): York University
Engaged Students
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
